| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.16 | 0.3 |